# Diagnostic Interest of the IRAP Protein (Insulin Regulated Amino Peptidase) in Insulin Resistance

> **NCT04028895** · NA · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 21 (actual)

## Conditions studied

- Insulin Resistance Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Dosage of IRAP during OGTT

## Key facts

- **NCT ID:** NCT04028895
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-14
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** stopped by the sponsor
- **Last updated:** 2022-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04028895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04028895, "Diagnostic Interest of the IRAP Protein (Insulin Regulated Amino Peptidase) in Insulin Resistance". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04028895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*